Investment Rating - The investment rating for the company is "Outperform the Market" [2][4][9] Core Insights - The company reported a retail performance for Q3 2025 with approximately 10% growth in both the main brand's offline retail and children's clothing, and around 20% growth in e-commerce [3][4] - The company continues to innovate products to meet diverse consumer needs and has expanded its super stores to 93 locations, maintaining stable inventory levels and slightly increasing discounts [4][6][9] - The company is expected to maintain a resilient growth trajectory, with projected net profits of 1.25 billion, 1.35 billion, and 1.48 billion yuan for 2025, 2026, and 2027 respectively, reflecting year-on-year growth rates of 8.5%, 8.7%, and 9.4% [4][10][11] Summary by Sections Retail Performance - In Q3 2025, the adult apparel segment saw approximately 10% growth, the children's apparel segment also grew by about 10%, and e-commerce experienced around 20% growth, with growth rates remaining stable compared to previous quarters [4][5][6] Product Innovation - The company has launched new products across various categories, including running shoes with enhanced waterproof technology, basketball shoes with advanced design features, and children's shoes tailored for young athletes [6][7] Channel Expansion - The number of super stores has increased to 93, with 44 new stores opened in Q3. These stores focus on a comprehensive product range and a self-service shopping model [6][7][9] Financial Projections - The company forecasts revenue growth of 21% in 2023, 19.6% in 2024, and 11% in 2025, with net profit growth of 28.7% in 2023 and 19.5% in 2024 [10][14]

证券研究报告 港股通 2025 年 10 月 14 日│中国香港 互联网 哔哩哔哩-W (9626 HK) 社区生态稳健，商业化成熟向前 游戏：老游戏长线运营，品类年轻化持续推进 游戏业务凭借对年轻用户需求的深刻理解，以及与社区生态的天然协同，实 现强势复苏。游戏业务 24 年实现收入 56 亿元，同比增长 40%，其中独代& 自研收入 44.3 亿元，同比大增 74%，主要得益于新游戏《三国：谋定天下》 发布。平台战略上聚焦长线运营与年轻化品类，一方面通过精细化运营让 《FGO》《碧蓝航线》等老产品持续贡献稳定流水；另一方面，自研与独 代并行的策略成效显著，《三国：谋定天下》作为公司首款 SLG 游戏，凭 借创新玩法与社区营销成功破圈，年底上线《三国：百将牌》有望延续品类 年轻化的成功经验，带来收入和利润弹性。 我们与市场观点不同之处 市场关注焦点集中在公司的估值体系与成长确定性，但是我们认为平台价值 仍然没有完全被挖掘，一方面自身社区壁垒优势突出，年轻用户占比高，活 跃用户持续增长，垂直平台壁垒深厚。另一方面市场普遍认为公司广告效率 较低，但事实上经过 3 年来的内部建设，我们预计在生成式 AI 辅助的推 ...

Investment Rating - The report maintains a "Buy" rating for the company, indicating a positive outlook for its stock performance in the coming months [8]. Core Insights - The company has demonstrated strong resilience in the retail environment, achieving approximately 10% year-on-year growth in both its main brand and children's clothing lines, with e-commerce sales growing around 20% [8]. - The company is expanding its offline presence through innovative channel strategies, including the rapid rollout of "super stores," which have shown significant growth potential [8]. - The product matrix continues to evolve with new iterations in core categories, showcasing technological advancements and innovation [8]. - The One Way brand is being revitalized with a focus on the mid-to-high-end outdoor market, with new store openings and a refreshed product line [8]. - The company is expected to maintain a strong growth trajectory, with projected net profits of 12.6 billion, 13.9 billion, and 15.1 billion RMB for FY2025E, FY2026E, and FY2027E respectively, corresponding to price-to-earnings ratios of 9, 8, and 7 [8]. Financial Data and Earnings Forecast - Revenue projections are as follows: - FY2023: 84.23 billion RMB - FY2024: 100.7 billion RMB - FY2025E: 111.8 billion RMB - FY2026E: 121.4 billion RMB - FY2027E: 130.8 billion RMB - Year-on-year growth rates for revenue are projected at 21% for FY2023, 20% for FY2024, and gradually decreasing to 8% by FY2027 [7][18]. - The net profit forecast is as follows: - FY2023: 9.6 billion RMB - FY2024: 11.5 billion RMB - FY2025E: 12.6 billion RMB - FY2026E: 13.9 billion RMB - FY2027E: 15.1 billion RMB - The gross margin is expected to improve slightly from 41.1% in FY2023 to 41.9% in FY2027 [7][18].

Investment Rating - The report maintains a "Buy-B" rating for the company 361 Degrees (01361.HK) [1][6] Core Insights - The company has demonstrated healthy growth in retail sales across both offline and online channels, with a notable 10% year-on-year increase in retail sales for its main brand and children's clothing in Q3 2025, and a 20% increase in e-commerce sales [3][4][6] - The company is expanding its premium store count, reaching 93 stores by the end of Q3 2025, and aims to exceed 100 stores by year-end [5][6] - The company is actively participating in the marathon sector, becoming a top partner for the 2025 Tangshan Marathon and a sponsor for the 2025 Taishan Marathon, which is expected to drive sales growth in the running category [4][6] Financial Performance - For the fiscal year 2025, the company is projected to achieve a revenue of 11,367 million HKD, reflecting a year-on-year growth of 12.8% [10][11] - The net profit for 2025 is estimated at 1,285 million HKD, with a year-on-year growth of 11.9% [10][11] - The company's EPS is forecasted to be 0.62 HKD for 2025, with corresponding P/E ratios of approximately 8.7, 7.8, and 7.1 for the years 2025, 2026, and 2027 respectively [6][10]

Investment Rating - The investment rating for the company is "Buy" (maintained) [2] Core Insights - The company has demonstrated strong resilience in the retail environment, achieving approximately 10% year-on-year growth in both its main brand and children's clothing lines in Q3 2025, with e-commerce sales growing around 20% [8] - The company maintains a healthy inventory level with a stable discount rate, achieving a channel inventory turnover ratio of 4.5-5 times and a terminal discount rate close to 30% [8] - The company is innovating its channels significantly, with rapid expansion of its "super brand stores," opening 23 new stores in September alone, and plans to open at least 100 stores by the end of the year [8] - The product matrix continues to refresh, showcasing technological advancements in core categories, including new iterations of running shoes and basketball shoes [8] - The One Way brand is re-entering the offline market, focusing on the mid-to-high-end outdoor market, with new store openings and a product line adjustment to align with current outdoor trends [8] - The company has been deepening its operational capabilities in product, brand, and channel over the past two decades, positioning itself for sustained growth above industry averages [8] Financial Data and Profit Forecast - Revenue projections for FY2023 to FY2027 are as follows: - FY2023: 84.23 billion RMB - FY2024: 100.7 billion RMB - FY2025E: 111.8 billion RMB - FY2026E: 121.4 billion RMB - FY2027E: 130.8 billion RMB - Net profit projections for the same period are: - FY2023: 9.6 billion RMB - FY2024: 11.5 billion RMB - FY2025E: 12.6 billion RMB - FY2026E: 13.9 billion RMB - FY2027E: 15.1 billion RMB - The company maintains a stable gross margin, projected to increase slightly from 41.1% in FY2023 to 41.9% in FY2027 [6][17]

Investment Rating - The report gives a "Strong Buy" investment rating for the company [4][8]. Core Insights - Dongyangguang Pharmaceutical has established a fully integrated R&D, production, and sales platform, focusing on three major areas: anti-infection, chronic diseases (metabolism), and oncology. The company has a rich pipeline of innovative drugs and is experiencing rapid growth in its already launched products [1][8]. Financial Data and Valuation - Total revenue is projected to grow from 6.386 billion CNY in 2023 to 6.995 billion CNY in 2027, with a peak growth rate of 67% in 2023 followed by a decline of 37% in 2024 [3]. - Operating profit is expected to increase significantly from 218.9 million CNY in 2023 to 1.679 billion CNY in 2027, with a remarkable growth of 339% in 2023 [3]. - The net profit attributable to shareholders is forecasted to turn positive in 2025, reaching 564 million CNY, and further increasing to 1.419 billion CNY by 2027 [3]. - The company’s PE ratio is projected to decrease from 137.1 in 2023 to 17.9 in 2027, indicating improving valuation metrics as profitability increases [3]. Business Overview - Dongyangguang Pharmaceutical is recognized as the first Chinese company to go public through a reverse merger, marking a significant milestone in its development [1][13]. - The company has a clear and stable shareholding structure, with the largest shareholder holding 43.35% of the shares [4][16]. R&D Pipeline - The company’s R&D focuses on three main therapeutic areas: - **Anti-infection**: Targeting functional cure for chronic hepatitis B with innovative therapies including siRNA and ASO technologies [8][27]. - **Chronic diseases**: The drug Ifenison is in Phase III clinical trials for idiopathic pulmonary fibrosis (IPF) and shows promising results [43][44]. - **Oncology**: The company is developing multiple platforms including PROTAC and CAR-T technologies, with key products like Clifofitinib and HEC921 showing significant potential [71][75][77]. Market Position and Growth Potential - The pediatric product line is seen as a core competitive advantage, while the infection and chronic disease lines are expected to drive future growth [8][27]. - The company is well-positioned to capitalize on the growing market for chronic disease treatments, particularly in the metabolic disease sector, with a comprehensive product matrix [54][68]. Conclusion - The report emphasizes the company's strong innovation pipeline and growth potential, leading to a favorable investment outlook [8][9].

Investment Rating - The report maintains a "Recommended" investment rating for 361 Degrees (1361.HK) [3][11]. Core Insights - The company reported a strong operational performance in Q3 2025, with a 10% year-on-year increase in retail sales for both the main brand and children's clothing, and a 20% increase in overall e-commerce platform revenue [3][6]. - The company is actively enhancing its operational performance through product upgrades, brand building, and channel development, including collaborations with Meituan for online sales [6]. - The company is positioned to benefit from the growth in both adult and children's apparel segments, alongside the sports and outdoor activity market, indicating strong resilience in both short and long-term growth [6]. Financial Summary - Revenue projections for 2025-2027 are estimated at 113.4 billion, 126.6 billion, and 140.8 billion CNY, representing year-on-year growth of 12.5%, 11.7%, and 11.2% respectively [6][9]. - Net profit forecasts for the same period are 12.9 billion, 14.7 billion, and 16.6 billion CNY, with growth rates of 12.5%, 13.4%, and 13.0% [6][9]. - The company maintains a gross margin of approximately 41% and a net margin of around 11.4% [9]. Key Financial Ratios - The projected P/E ratios for 2025-2027 are 8.7, 7.7, and 6.8, indicating a potentially attractive valuation [9]. - The projected ROE for 2025-2027 is around 14.7% to 14.6%, suggesting stable profitability [9]. - The asset-liability ratio is expected to be around 28.4% in 2025, indicating a healthy balance sheet [9]. Operational Highlights - As of September 30, 2025, the company has expanded its national store count to 93, reflecting ongoing channel development [6]. - The company is the official partner of the 20th Asian Games, enhancing its brand visibility and market presence [6].

Investment Rating - The report maintains a "Buy" rating for Tencent Holdings [1][22][25] Core Insights - Strong advertising performance, sufficient growth momentum in gaming, and potential acceleration in cloud business are highlighted as key drivers for Tencent's growth [1][22] - The report anticipates Tencent's revenue for Q3 2025 to reach 188.6 billion RMB, representing a year-over-year growth of 13% [6][22] - The expected non-IFRS net profit for Q3 2025 is projected to be 67.9 billion RMB, a 13% increase year-over-year [6][22] Financial Performance Forecast 1. **Overall Performance**: - Revenue is expected to be 188.6 billion RMB in Q3 2025, with a gross margin of 56% and a gross profit of 105.1 billion RMB [6][22] - Non-IFRS operating profit is projected at 71.4 billion RMB, a 17% increase year-over-year [6][22] 2. **Gaming Segment**: - Anticipated revenue growth of 14% year-over-year, with domestic and overseas growth rates of 8% and 29% respectively [7][10][22] - Notable titles like "Delta Force" are expected to generate over 8 billion RMB in a single quarter [10][22] 3. **Marketing Services**: - Expected revenue growth of 22% year-over-year, driven by the WeChat ecosystem and strong performance in video accounts and mini-programs [14][22] - Video account advertising revenue is projected to grow over 60% year-over-year [14][22] 4. **Financial Technology and Enterprise Services**: - Revenue growth of 11% year-over-year is anticipated, with cloud services expected to exceed 20% growth [20][22] - The launch of "Tenpay Global" aims to enhance payment services in international markets [21][22] Earnings Forecast and Valuation - Revenue projections for Tencent from 2025 to 2027 are 748.6 billion RMB, 840.3 billion RMB, and 923.6 billion RMB respectively [22][23] - Non-IFRS net profit estimates for the same period are 257.8 billion RMB, 295.4 billion RMB, and 329.9 billion RMB [22][23] - The target market capitalization for Tencent in 2026 is set at 6.5 trillion RMB, corresponding to a target price of 773 HKD [22][23]

Investment Rating - The investment rating for the company is "Accumulate" with a target price of HKD 14.14, indicating a potential upside from the current price of HKD 11.43 [4]. Core Insights - The company reported a revenue of HKD 3.181 billion for the first half of 2025, reflecting a year-on-year growth of 40.0%. The social business segment contributed approximately HKD 2.834 billion, growing by 37.0% year-on-year. Notably, the SUGO platform saw revenue growth exceeding 100% and profit growth over 150% [1]. - The company is actively expanding its innovative product offerings, including the launch of the AI creative content community Aippy, which allows users to generate interactive content using natural language. This aligns with the company's strategy to deepen its presence in the global social entertainment market [2]. - The company has adjusted its revenue forecasts for FY2025-FY2027, increasing the projections from HKD 67.1 billion, HKD 77.5 billion, and HKD 89.5 billion to HKD 69.1 billion, HKD 85.5 billion, and HKD 102.5 billion respectively. The net profit estimates have also been revised upwards [3]. Summary by Sections Financial Performance - For the first half of 2025, the adjusted EBITDA reached HKD 650 million, representing a 44.0% increase year-on-year. The diversified product portfolio and AI technology integration have enhanced the company's strategic foresight and risk resilience [1]. Market Expansion - The company has established a regional headquarters in Riyadh, Saudi Arabia, to strengthen its ties with the Middle Eastern market. Additionally, a global headquarters was set up in Hong Kong, marking a new phase in the company's globalization strategy [2]. Product Development - The company is focusing on innovative products, with significant investments in short video content and social e-commerce, contributing to a 70.5% year-on-year revenue increase in its innovative business segment [1][2].

Investment Rating - The investment rating for the company is "Buy" (maintained) [5] Core Views - The acquisition of a 53% stake in Fulu Family further expands the brand matrix of the company [5] - The beer industry has a large market size and consumer base, with increasing demand for high-quality and diverse products, which is expected to open up opportunities in the fresh beer market [8] - The company is expected to leverage its existing supply chain advantages and franchisee strengths to enhance its brand presence in the fresh beer sector [8] Financial Performance and Forecast - Revenue projections for the company are as follows: - 2023: 20,302.47 million RMB - 2024: 24,828.87 million RMB (growth of 22.29%) - 2025E: 30,443.21 million RMB (growth of 22.61%) - 2026E: 36,691.03 million RMB (growth of 20.52%) - 2027E: 42,410.49 million RMB (growth of 15.59%) [6] - Net profit forecasts are as follows: - 2023: 3,137.34 million RMB - 2024: 4,436.50 million RMB (growth of 41.41%) - 2025E: 5,425.05 million RMB (growth of 22.28%) - 2026E: 6,586.02 million RMB (growth of 21.40%) - 2027E: 7,670.19 million RMB (growth of 16.46%) [6] - The price-to-earnings (P/E) ratios for the upcoming years are projected as follows: - 2025E: 26.88 - 2026E: 22.14 - 2027E: 19.01 [6] Company Overview - The company has acquired a 51% stake in Fulu Family for an investment of 286 million RMB, with the acquisition expected to enhance its brand portfolio [8] - Fulu Family operates approximately 1,200 stores across 28 provinces in China, primarily using a franchise model for expansion [8] - The company aims to maintain a high-quality and affordable product positioning in the fresh beer market, which includes a diverse product range [8]